Nektar Therapeutics Statistics
Total Valuation
NKTR has a market cap or net worth of $2.45 billion. The enterprise value is $1.90 billion.
| Market Cap | 2.45B |
| Enterprise Value | 1.90B |
Important Dates
The last earnings date was Thursday, August 13, 2026, after market close.
| Earnings Date | Aug 13, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
NKTR has 34.14 million shares outstanding. The number of shares has increased by 73.25% in one year.
| Current Share Class | 34.14M |
| Shares Outstanding | 34.14M |
| Shares Change (YoY) | +73.25% |
| Shares Change (QoQ) | +33.63% |
| Owned by Insiders (%) | 0.37% |
| Owned by Institutions (%) | 89.08% |
| Float | 28.53M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 45.17 |
| Forward PS | 59.88 |
| PB Ratio | 2.70 |
| P/TBV Ratio | 2.73 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 35.12 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 10.42, with a Debt / Equity ratio of 0.15.
| Current Ratio | 10.42 |
| Quick Ratio | 9.71 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -4.22 |
Financial Efficiency
Return on equity (ROE) is -35.75% and return on invested capital (ROIC) is -51.66%.
| Return on Equity (ROE) | -35.75% |
| Return on Assets (ROA) | -12.54% |
| Return on Invested Capital (ROIC) | -51.66% |
| Return on Capital Employed (ROCE) | -12.76% |
| Weighted Average Cost of Capital (WACC) | 11.00% |
| Revenue Per Employee | $866,492 |
| Profits Per Employee | -$2.49M |
| Employee Count | 63 |
| Asset Turnover | 0.08 |
| Inventory Turnover | n/a |
Taxes
In the past 12 months, NKTR has paid $64,000 in taxes.
| Income Tax | 64,000 |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has increased by +140.29% in the last 52 weeks. The beta is 1.16, so NKTR's price volatility has been higher than the market average.
| Beta (5Y) | 1.16 |
| 52-Week Price Change | +140.29% |
| 50-Day Moving Average | 71.07 |
| 200-Day Moving Average | 64.65 |
| Relative Strength Index (RSI) | 46.74 |
| Average Volume (20 Days) | 539,053 |
Short Selling Information
The latest short interest is 6.17 million, so 18.07% of the outstanding shares have been sold short.
| Short Interest | 6.17M |
| Short Previous Month | 6.30M |
| Short % of Shares Out | 18.07% |
| Short % of Float | 21.62% |
| Short Ratio (days to cover) | 9.04 |
Income Statement
In the last 12 months, NKTR had revenue of $54.59 million and -$157.13 million in losses. Loss per share was -$6.47.
| Revenue | 54.59M |
| Gross Profit | 54.59M |
| Operating Income | -130.64M |
| Pretax Income | -157.06M |
| Net Income | -157.13M |
| EBITDA | -129.95M |
| EBIT | -130.64M |
| Loss Per Share | -$6.47 |
Balance Sheet
The company has $684.34 million in cash and $135.93 million in debt, with a net cash position of $548.41 million or $16.06 per share.
| Cash & Cash Equivalents | 684.34M |
| Total Debt | 135.93M |
| Net Cash | 548.41M |
| Net Cash Per Share | $16.06 |
| Equity (Book Value) | 903.12M |
| Book Value Per Share | 26.46 |
| Working Capital | 668.42M |
Cash Flow
In the last 12 months, operating cash flow was -$233.79 million and capital expenditures -$941,000, giving a free cash flow of -$234.73 million.
| Operating Cash Flow | -233.79M |
| Capital Expenditures | -941,000 |
| Depreciation & Amortization | 693,000 |
| Net Borrowing | 287.55M |
| Free Cash Flow | -234.73M |
| FCF Per Share | -$6.87 |
Margins
Gross margin is 100.00%, with operating and profit margins of -239.32% and -287.84%.
| Gross Margin | 100.00% |
| Operating Margin | -239.32% |
| Pretax Margin | -287.72% |
| Profit Margin | -287.84% |
| EBITDA Margin | -238.05% |
| EBIT Margin | -239.32% |
| FCF Margin | n/a |
Dividends & Yields
NKTR does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -73.25% |
| Shareholder Yield | -73.25% |
| Earnings Yield | -6.37% |
| FCF Yield | -9.52% |
Analyst Forecast
The average price target for NKTR is $144.40, which is 101.25% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $144.40 |
| Price Target Difference | 101.25% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 12 |
| Revenue Growth Forecast (3Y) | -14.00% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
The last stock split was on June 9, 2025. It was a reverse split with a ratio of 1:15.
| Last Split Date | Jun 9, 2025 |
| Split Type | Reverse |
| Split Ratio | 1:15 |
Scores
NKTR has an Altman Z-Score of -0.21 and a Piotroski F-Score of 3. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | -0.21 |
| Piotroski F-Score | 3 |